Rationale and Design of a Large-Scale Trial Using Atrial Natriuretic Peptide (ANP) as an Adjunct to Percutaneous Coronary Intervention for ST-Segment Elevation …

M Asakura, K Jiyoong, T Minamino, Y Shintani… - Circulation …, 2004 - jstage.jst.go.jp
Background The benefits of percutaneous coronary intervention (PCI) in acute myocardial
infarction (AMI) are limited by reperfusion injury. In animal models, atrial natriuretic peptide …
被引用次数：57 相关文章
[PDF] niph.go.jp

[PDF][PDF] C|| N|| CAL| NVESTIGATIONS

M Asakura, K Jiyoong, T Minamino… - Circulation …, 2004 - mhlw-grants.niph.go.jp
Background The benefits of percutaneous coronary intervention (PCI) in acute myocardial
infarction (AMI) are limited by reperfusion injury. In animal models, atrial natriuretic peptide …

Rationale and design of a large-scale trial using atrial natriuretic peptide (ANP) as an adjunct to percutaneous coronary intervention for ST-segment elevation acute …

M Asakura, K Jiyoong, T Minamino… - … : official journal of …, 2004 - pubmed.ncbi.nlm.nih.gov
Background The benefits of percutaneous coronary intervention (PCI) in acute myocardial
infarction (AMI) are limited by reperfusion injury. In animal models, atrial natriuretic peptide …
[PDF] archive.org

[PDF][PDF] Rationale and Design of a Large-Scale Trial Using Atrial Natriuretic Peptide (ANP) as an Adjunct to Percutaneous Coronary Intervention for ST-Segment …

M Asakura, K Jiyoong, T Minamino, Y Shintani… - Circulation …, 2004 - scholar.archive.org
Background The benefits of percutaneous coronary intervention (PCI) in acute myocardial
infarction (AMI) are limited by reperfusion injury. In animal models, atrial natriuretic peptide …

Rationale and Design of a Large-Scale Trial Using Atrial Natriuretic Peptide (ANP) as an Adjunct to Percutaneous Coronary Intervention for ST-Segment Elevation …

M ASAKURA, J KIM, T MINAMIMO, Y SHINTANI… - Circulation …, 2004 - jglobal.jst.go.jp
Rationale and Design of a Large-Scale Trial Using Atrial Natriuretic Peptide (ANP) as an
Adjunct to Percutaneous Coronary Intervention for ST-Segment Elevation Acute Myocardial …

Rationale and design of a large-scale trial using atrial natriuretic peptide (ANP) as an adjunct to percutaneous coronary intervention for ST-segment elevation acute …

M Asakura, K Jiyoong, T Minamino… - … : Official Journal of the …, 2004 - europepmc.org
Background The benefits of percutaneous coronary intervention (PCI) in acute myocardial
infarction (AMI) are limited by reperfusion injury. In animal models, atrial natriuretic peptide …

Rationale and Design of a Large-Scale Trial Using Atrial Natriuretic Peptide (ANP) as an Adjunct to Percutaneous Coronary Intervention for ST-Segment Elevation …

A Masanori, J Kim, M Tetsuo, S Yasunori, A Hiroshi… - 日本循環器學誌, 2004 - cir.nii.ac.jp
Background The benefits of percutaneous coronary intervention (PCI) in acute myocardial
infarction (AMI) are limited by reperfusion injury. In animal models, atrial natriuretic peptide …

Rationale and Design of a Large-Scale Trial Using Atrial Natriuretic Peptide (ANP) as an Adjunct to Percutaneous Coronary Intervention for ST-Segment Elevation …

M Asakura, K Jiyoong, T Minamino, Y Shintani… - Circulation …, 2004 - jlc.jst.go.jp
Background The benefits of percutaneous coronary intervention (PCI) in acute myocardial
infarction (AMI) are limited by reperfusion injury. In animal models, atrial natriuretic peptide …

Rationale and Design of a Large-Scale Trial Using Atrial Natriuretic Peptide (ANP) as an Adjunct to Percutaneous Coronary Intervention for ST-Segment Elevation …

M Asakura, K Jiyoong, T Minamino, Y Shintani… - Circulation …, 2004 - jlc.jst.go.jp
Background The benefits of percutaneous coronary intervention (PCI) in acute myocardial
infarction (AMI) are limited by reperfusion injury. In animal models, atrial natriuretic peptide …